Denali Therapeutics (DNLI) FY Conference June 10, 2025 01:20 PM ET Speaker0 Calls is investigated. We're ready. Speaker1 Great. Good afternoon, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. I'm really pleased to be joined by the Denali team. So with me I have Ryan Watts, CEO, and Alex Schutz, who's Chief Operating and Chief Financial Officer. Maybe to start here, could you just provide an overview of where Denali stands today in the context of your ...